Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Weizman A, Huang B, Berel D, Targan SR, Dubinsky M, Fleshner P, Ippoliti A, Kaur M, Panikkath D, Brant S, Oikonomou I, Duerr R, Rioux J, Silverberg M, Rotter JI, Vasiliauskas E, Haritunians T, Shih D, Li D, Melmed GY, McGovern DP.

Inflamm Bowel Dis. 2014 Mar;20(3):525-33. doi: 10.1097/01.MIB.0000442011.60285.68.

2.
3.

Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.

Goldberg I, Finkel O, Gat A, Sprecher E, de Morentin HM.

Isr Med Assoc J. 2014 Mar;16(3):168-70.

4.

Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.

Ampuero J, Rojas-Feria M, Castro-Fernández M, Cano C, Romero-Gómez M.

J Gastroenterol Hepatol. 2014 Feb;29(2):291-5. doi: 10.1111/jgh.12352.

PMID:
23927379
5.

Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.

Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.

PMID:
27149138
6.

Mucocutaneous manifestations in inflammatory bowel disease.

Yüksel I, Başar O, Ataseven H, Ertuğrul I, Arhan M, Ibiş M, Dağli U, Demirel BT, Ulker A, Seçilmiş S, Saşmaz N.

Inflamm Bowel Dis. 2009 Apr;15(4):546-50. doi: 10.1002/ibd.20807.

PMID:
19023896
7.

Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.

Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K.

Medicine (Baltimore). 2008 Sep;87(5):281-93. doi: 10.1097/MD.0b013e318187cc9c.

8.

Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Vavricka SR, Galván JA, Dawson H, Soltermann A, Biedermann L, Scharl M, Schoepfer AM, Rogler G, Prinz Vavricka MB, Terracciano L, Navarini A, Zlobec I, Lugli A, Greuter T.

J Crohns Colitis. 2018 Feb 28;12(3):347-354. doi: 10.1093/ecco-jcc/jjx158.

9.

TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.

Ciccacci C, Biancone L, Di Fusco D, Ranieri M, Condino G, Giardina E, Onali S, Lepre T, Pallone F, Novelli G, Borgiani P.

J Crohns Colitis. 2013 Feb;7(1):44-52. doi: 10.1016/j.crohns.2012.02.020. Epub 2012 Mar 24.

PMID:
22445837
10.

Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.

Card TR, Langan SM, Chu TP.

Dig Dis Sci. 2016 Sep;61(9):2619-26. doi: 10.1007/s10620-016-4195-1. Epub 2016 May 19.

11.

Important cutaneous manifestations of inflammatory bowel disease.

Trost LB, McDonnell JK.

Postgrad Med J. 2005 Sep;81(959):580-5. Review.

12.

Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?

Walker D, Orchard T.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S200-1. doi: 10.1002/ibd.20637. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816647
13.

Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.

Taleban S, Li D, Targan SR, Ippoliti A, Brant SR, Cho JH, Duerr RH, Rioux JD, Silverberg MS, Vasiliauskas EA, Rotter JI, Haritunians T, Shih DQ, Dubinsky M, Melmed GY, McGovern DP.

J Crohns Colitis. 2016 Jan;10(1):43-9. doi: 10.1093/ecco-jcc/jjv178. Epub 2015 Oct 8.

14.

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N.

Am J Gastroenterol. 2001 Apr;96(4):1116-22.

PMID:
11316157
15.

Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD.

Tremaine WJ.

Inflamm Bowel Dis. 1998 Feb;4(1):68-9; discussion 73. No abstract available.

PMID:
9552230
16.

[Cutaneous manifestations in inflammatory bowel disease].

Chavez-Álvarez S, Gómez-Flores M, Ocampo-Candiani J.

Gac Med Mex. 2016 Sep - Oct;152(5):622-630. Review. Spanish.

17.

Cutaneous manifestations in inflammatory bowel disease.

Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, Griga T.

Z Gastroenterol. 2001 Feb;39(2):137-44.

PMID:
11253504
18.

Dermatological signs during inflammatory bowel diseases.

Feliciani C, De Simone C, Amerio P.

Eur Rev Med Pharmacol Sci. 2009 Mar;13 Suppl 1:15-21. Review.

PMID:
19530507
19.

Dermatologic manifestations in inflammatory bowel disease in Tunisia.

Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, Boubaker J, Mokni M, Filali A, Ben Osman A.

Tunis Med. 2012 Mar;90(3):252-7.

PMID:
22481199
20.

Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease.

Freeman HJ.

Can J Gastroenterol. 2005 Oct;19(10):603-6.

PMID:
16247522

Supplemental Content

Support Center